证券代码：300848 证券简称：美瑞新材 公告编号：2025-064 董事会决议通过的本报告期优先股利润分配预案 □适用 √不适用 二、公司基本情况 一、重要提示 本半年度报告摘要来自半年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投 资者应当到证监会指定媒体仔细阅读半年度报告全文。 所有董事均已出席了审议本报告的董事会会议。 非标准审计意见提示 □适用 √不适用 董事会审议的报告期利润分配预案或公积金转增股本预案 □适用 √不适用 公司计划不派发现金红利，不送红股，不以公积金转增股本。 前10名股东及前10名无限售流通股股东因转融通出借/归还原因导致较上期发生变化 1、公司简介 ■ 2、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 √否 ■ 3、公司股东数量及持股情况 单位：股 ■ 持股5%以上股东、前10名股东及前10名无限售流通股股东参与转融通业务出借股份情况 □适用 √不适用 □适用 √不适用 公司是否具有表决权差异安排 □是 √否 4、控股股东或实际控制人变更情况 控股股东报告期内变更 □适用 √不适用 公司报告期控股股东未发生变更。 实际控制人报告期 ...

Group 1 - The fourth meeting of the board of directors of Meirui New Materials Co., Ltd. was held on August 23, 2025, with all seven directors present, confirming the legality and validity of the meeting [2][3] - The board approved the proposal for capital increase to Meirui Technology to enhance its financial strength and alleviate liquidity pressure, aligning with the company's strategic development plan [4] - The capital increase will result in an increased shareholding ratio for the company in Meirui Technology, which remains a consolidated subsidiary, and will not significantly impact the company's operational and financial status [4]

Meeting Overview - The fourth special meeting of the independent directors of Miracll New Materials Co., Ltd. was held on August 23, 2025, in a combination of on-site and remote formats [1] - The meeting was convened and chaired by independent director Mr. Tang Yun, with all three independent directors present [1] Meeting Resolutions - The independent directors unanimously agreed that the proposed capital increase and related party transaction are in line with the operational development needs of the subsidiary Miracll Technology, promoting the development of new business and aligning with the company's development plan [1] - The pricing for the related party transaction is based on the net asset value per share of Miracll Technology as assessed by an asset appraisal agency as of June 30, 2025, ensuring no harm to the interests of the company and all shareholders, particularly minority investors [1] - The independent directors decided to submit the related party transaction matter to the board for review, with related directors required to abstain from voting [1]

证券代码：300848 证券简称：美瑞新材 公告编号：2025-063 美瑞新材料股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 为使投资者全面了解公司的财务状况和经营成果，公司《2025 年半年度报告》及《2025 年半年度报告摘要》于 2025 年 8 月 26 日在中国证监会指定的创业板信息披露网站巨潮资 讯网(www.cninfo.com.cn)上披露，敬请广大投资者注意查阅。 特此公告。 美瑞新材料股份有限公司 董事会 美瑞新材料股份有限公司 | 地址：烟台市开发区长沙大街 35 号 | 电话：+86-535-3979898 | 网址： www.miracll.com 第 1 页 共 1 页 美瑞新材料股份有限公司（以下简称"公司"）于 2025 年 8 月 23 日召开了第四届董 事会第七次会议，审议通过了《2025 年半年度报告全文及摘要》。 ...

Fundraising Overview - The company successfully issued 13,698,824 shares at a price of RMB 14.38 per share, raising a total of RMB 196 million, with a net amount of RMB 195 million after deducting fees [1][2] - The funds were deposited in two dedicated accounts at Bank of Communications and Bank of China [1][2] Fund Utilization - During the reporting period, RMB 40.69 million was used for project expenditures, and RMB 1,050.13 was spent on fees, while RMB 4,494.53 was earned from interest [2] - The remaining balance in the fundraising accounts as of June 30, 2025, was RMB 6.72 million [2][7] Fund Management - The company established a fundraising management system in compliance with regulatory requirements, ensuring proper storage, management, and usage of the funds [3][4] - A tripartite supervision agreement was signed with the underwriter and banks to clarify rights and obligations regarding fund management [3] Compliance and Reporting - The company adhered to all regulatory guidelines and internal management protocols, ensuring no violations occurred in the use of the funds [4][7] - There were no changes in the feasibility of projects funded by the raised capital during the reporting period [6][8] Financial Management - The company utilized RMB 411 million of idle funds for cash management, with a balance of RMB 149 million in financial products [6][9] - As of June 30, 2025, no funds were used for temporary working capital or other unauthorized purposes [7][9]

Group 1 - The report details the financial interactions between the listed company and its controlling shareholders, including non-operating fund usage and related party transactions [1] - The total amount of non-operating funds utilized by the controlling shareholders and their affiliates is specified, with a cumulative occurrence amount of 19.65 million yuan and a year-end balance of 2 million yuan [1] - The report also highlights the operational transactions with other related parties, indicating a total of 219.65 million yuan in cumulative occurrence amount and a year-end balance of 202 million yuan [1] Group 2 - The financial data includes specific amounts related to the company's subsidiaries, such as 200 million yuan in other receivables from a wholly-owned subsidiary [1] - The report identifies the nature of the transactions, categorizing them as business interactions and operational exchanges [1] - Key personnel responsible for the financial reporting are mentioned, including the legal representative and accounting heads [1]

Core Viewpoint - The report presents the financial performance and operational highlights of Miracll Chemical Co., Ltd. for the first half of 2025, emphasizing growth in revenue and net profit while outlining the company's strategic focus on polyurethane new materials and functional chemical products. Company Overview and Financial Indicators - Miracll Chemical Co., Ltd. is a leading manufacturer of polyurethane new materials (TPU, PUR, PUD, PBS) and functional chemical raw materials (special isocyanates, special amines) with applications across various industries including consumer electronics, automotive, and green energy [4][5]. - The company reported a slight increase in revenue of 0.02% year-on-year, totaling approximately 800.7 million yuan, while net profit attributable to shareholders rose by 25.25% to approximately 39.1 million yuan [3][4]. Business Operations - The company operates two main production bases located in Yantai, Shandong, and Hebi, Henan, focusing on the production of polyurethane new materials and functional chemical raw materials respectively [4][5]. - The TPU product line accounts for over 90% of sales, with ongoing development in other products like PUR, PUD, and PBS, which are expected to grow rapidly [4][5]. Product Characteristics and Applications - TPU is highlighted for its excellent mechanical properties, temperature resistance, and environmental durability, making it suitable for a wide range of applications from consumer electronics to automotive components [4][5]. - The company is the only publicly listed entity in China primarily focused on TPU, establishing a competitive edge through quality and innovation [4][5]. Special Isocyanates and Amines - The company specializes in producing special isocyanates such as HDI, CHDI, and PPDI, which are characterized by their superior mechanical properties and stability, suitable for high-performance applications [6][7]. - The production of special amines (PNA, PPDA, CHDA) is also emphasized, with the company holding a leading position in global production capacity for these materials [8][9]. Market Position and Competitive Advantage - The company has established a strong market presence and competitive advantage through continuous technological innovation and a focus on high-quality, differentiated products [4][5][6]. - The strategic focus on upstream supply chain integration ensures a stable supply of high-quality raw materials, enhancing the company's resilience and competitive positioning in the market [12].

Core Viewpoint - The company reported stable revenue and significant profit growth in the first half of 2025, driven by product innovation and strategic expansion in production capacity [6][7]. Financial Performance - The company's operating income for the reporting period was approximately 800.70 million yuan, showing a slight increase of 0.02% compared to the same period last year [6]. - The net profit attributable to shareholders was approximately 39.12 million yuan, representing a year-on-year increase of 25.25% [6]. - The net cash flow from operating activities improved significantly, reaching approximately 157.63 million yuan, a turnaround from a negative cash flow of approximately -225.99 million yuan in the previous year [6]. - Basic and diluted earnings per share both increased by 12.50% to 0.09 yuan [6]. Asset and Equity Position - Total assets at the end of the reporting period were approximately 4.21 billion yuan, reflecting a growth of 9.34% from the previous year [3]. - The net assets attributable to shareholders increased by 15.48% to approximately 1.52 billion yuan [3]. Business Development and Innovation - The company has successfully launched several new products in the polyurethane segment, leveraging its technological advantages to maintain stable sales in a volatile market [6]. - The company is focusing on developing high-performance polyurethane materials, which are widely used in high-end coatings, adhesives, and automotive interiors [6]. - Significant breakthroughs in product applications include the successful use of PUR products in food packaging and the development of high-temperature resistant TPU materials [6]. Production Capacity Expansion - The company is constructing a new project for the annual production of 10,000 tons of expandable thermoplastic polyurethane elastomers, expected to commence operations in Q4 2024 [6][7]. - Another project for the annual production of 30,000 tons of water-based polyurethane is also underway, which will enhance production efficiency and profitability [7].

证券日报网讯 8月25日晚间，美瑞新材发布公告称，2025年上半年公司实现营业收入800，700，264.32 元，同比增长0.02%；归属于上市公司股东的净利润为39，122，131.87元，同比增长25.25%。 （文章来源：证券日报） ...

证券代码：300848 证券简称：美瑞新材 公告编号：2025-068 重要内容提示： 1、基于美瑞新材料股份有限公司（以下简称"公司"）整体战略发展规划与业务发展 需要，公司拟以自有资金向控股子公司美瑞科技（河南）有限公司（以下简称"美瑞科技"） 进行最高不超过 35,000 万元人民币的增资，最终增资额以增资协议签署内容为准。美瑞科 技其余股东均确认放弃本次增资的优先认缴权。本次增资完成后，美瑞科技仍为公司的控 股子公司，继续纳入公司合并报表范围。 美瑞新材料股份有限公司 关于拟对控股子公司增资暨关联交易的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 2、截至本公告披露日，本次交易标的公司涉及的审计、评估工作尚未完成，公司具体 增资金额等事项尚待确定，公司将在相关审计、评估工作完成后，再次召开董事会审议本 次交易事项及签署相关增资协议，并在董事会审议通过后提交股东会审议。 3、风险提示：标的公司美瑞科技在未来经营过程中可能面临宏观经济及行业政策变化、 市场竞争等不确定因素的影响，存在一定的市场风险、经营风险、管理风险以及投资失败 的风险等，公司将及 ...